465 related articles for article (PubMed ID: 28366815)
1. Liraglutide suppression of caloric intake competes with the intake-promoting effects of a palatable cafeteria diet, but does not impact food or macronutrient selection.
Hyde KM; Blonde GD; le Roux CW; Spector AC
Physiol Behav; 2017 Aug; 177():4-12. PubMed ID: 28366815
[TBL] [Abstract][Full Text] [Related]
2. Roux-en-Y gastric bypass in rats progressively decreases the proportion of fat calories selected from a palatable cafeteria diet.
Mathes CM; Letourneau C; Blonde GD; le Roux CW; Spector AC
Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R952-9. PubMed ID: 26864811
[TBL] [Abstract][Full Text] [Related]
3. Early Postoperative Exposure to High-Fat Diet Does Not Increase Long-Term Weight Loss or Fat Avoidance After Roux-en-Y Gastric Bypass in Rats.
Ismaeil A; Gero D; Boyle CN; Alceste D; Taha O; Spector AC; Lutz TA; Bueter M
Front Nutr; 2022; 9():834854. PubMed ID: 35495960
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
5. Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators.
Decara J; Arrabal S; Beiroa D; Rivera P; Vargas A; Serrano A; Pavón FJ; Ballesteros J; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
Biofactors; 2016 Nov; 42(6):600-611. PubMed ID: 27213962
[TBL] [Abstract][Full Text] [Related]
6. Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY
Dischinger U; Hasinger J; Königsrainer M; Corteville C; Otto C; Fassnacht M; Hankir M; Seyfried FJD
Front Endocrinol (Lausanne); 2020; 11():598843. PubMed ID: 33551994
[TBL] [Abstract][Full Text] [Related]
7. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.
Hansen G; Jelsing J; Vrang N
Acta Pharmacol Sin; 2012 Feb; 33(2):194-200. PubMed ID: 22301859
[TBL] [Abstract][Full Text] [Related]
8. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice.
Mathes CM; Ferrara M; Rowland NE
Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.
Mathes CM; Ferrara M; Rowland NE
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R67-75. PubMed ID: 18448611
[TBL] [Abstract][Full Text] [Related]
10. Gastric bypass in rats does not decrease appetitive behavior towards sweet or fatty fluids despite blunting preferential intake of sugar and fat.
Mathes CM; Bohnenkamp RA; Blonde GD; Letourneau C; Corteville C; Bueter M; Lutz TA; le Roux CW; Spector AC
Physiol Behav; 2015 Apr; 142():179-88. PubMed ID: 25660341
[TBL] [Abstract][Full Text] [Related]
11. Daily supplementation of dietary protein improves the metabolic effects of GLP-1-based pharmacotherapy in lean and obese rats.
Mietlicki-Baase EG; Koch-Laskowski K; McGrath LE; Krawczyk J; Pham T; Lhamo R; Reiner DJ; Hayes MR
Physiol Behav; 2017 Aug; 177():122-128. PubMed ID: 28433470
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic obesity in the weanling rat: dietary self-selection, actual macro-nutrient intake, caloric regulation and response to subsequent low palatability diet.
Bernardis LL; Luboshitzky R; Bellinger LL; McEwen G
Int J Obes; 1982; 6(4):369-82. PubMed ID: 7129749
[TBL] [Abstract][Full Text] [Related]
13. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
Smith GC; Vickers MH; Cognard E; Shepherd PR
Schizophr Res; 2009 Nov; 115(1):30-40. PubMed ID: 19679451
[TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone and macronutrient selection by obese Zucker rats (fa/fa).
Svec F; Abadie J; Browne ES; Porter JR
Appetite; 1995 Oct; 25(2):143-54. PubMed ID: 8561487
[TBL] [Abstract][Full Text] [Related]
15. Effects of the lipase inhibitor orlistat on intake and preference for dietary fat in rats.
Ackroff K; Sclafani A
Am J Physiol; 1996 Jul; 271(1 Pt 2):R48-54. PubMed ID: 8760203
[TBL] [Abstract][Full Text] [Related]
16. Effect of DHEA on macronutrient selection by Zucker rats.
Svec F; Porter J
Physiol Behav; 1996; 59(4-5):721-7. PubMed ID: 8778858
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
Le TDV; Fathi P; Watters AB; Ellis BJ; Besing GK; Bozadjieva-Kramer N; Perez MB; Sullivan AI; Rose JP; Baggio LL; Koehler J; Brown JL; Bales MB; Nwaba KG; Campbell JE; Drucker DJ; Potthoff MJ; Seeley RJ; Ayala JE
Mol Metab; 2023 Jun; 72():101718. PubMed ID: 37030441
[TBL] [Abstract][Full Text] [Related]
18. Feeding response of rats to no-fat and high-fat cakes.
Sclafani A; Weiss K; Cardieri C; Ackroff K
Obes Res; 1993 May; 1(3):173-8. PubMed ID: 16353351
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast.
Smith BK; Berthoud HR; York DA; Bray GA
Peptides; 1997; 18(2):207-11. PubMed ID: 9149292
[TBL] [Abstract][Full Text] [Related]
20. The effects of continuous morphine infusion on diet selection and body weight.
Gosnell BA; Krahn DD
Physiol Behav; 1993 Nov; 54(5):853-9. PubMed ID: 8248373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
